Cite
HARVARD Citation
Holmes, L. et al. (n.d.). A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes. Cardiovascular therapeutics. 34 (5), pp. 330-336. [Online].